Why the study?
Pericarditis can be an initial presentation or complication of rheumatic disease, and there is growing evidence for anti-inflammatory and immunosuppressive therapies with overlapping treatment strategies.
This review summarizes the evaluation, imaging, and management of pericarditis in patients with rheumatic diseases, highlighting the use of anti-inflammatory and immunosuppressive agents.
May aid pericarditis management in rheumatic diseases; leaves open optimal immunosuppression pending prospective trials.
This review summarizes the evaluation for underlying rheumatic conditions in patients presenting with acute pericarditis, treatment considerations for specific rheumatic conditions, and the role of imaging in diagnosis and monitoring. Pericarditis may be one of the initial presentations of a rheumatic disease or identified in a patient with known rheumatic disease. There is also growing evidence for using anti-inflammatory and immunosuppressive agents for treating recurrent pericarditis, which can overlap with the treatment of rheumatic diseases.
No takes yet. Share an insight, caveat, or question.
Kawano et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: